EVOLVE Study
Identifying Oxytocin Deficiency in Pituitary Disease
About the Study
We are doing this research to understand whether a single dose of a hormone pill (norethindrone acetate/ethinyl estradiol) could be used to identify individuals who have deficiency of the pituitary hormone oxytocin.
Oxytocin deficiency in individuals with arginine vasopressin deficiency (AVP-D; formerly known as central diabetes insipidus) has been linked to worse socioemotional health. Coming up with a way to identify individuals with oxytocin deficiency is an important first step towards our goal of improving care of individuals with oxytocin deficiency.
Who May Be Eligible?
Adults ages 35 years and older
Those who have been diagnosed with arginine vasopressin deficiency
Healthy volunteers who do not have arginine vasopressin deficiency
Study Staff
Clinical Research Coordinator
Thomas Bitar
Francesca Galbiati, MD
Elizabeth A. Lawson, MD MMSc
Principal Investigator
Clinical Fellow